K. J. Ransohoff (1, 2), J. C. Wu (1, 2)
(1) Department of Medicine (Division of Cardiology), Stanford University School of Medicine, Stanford, California, USA; (2) Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, California, USA
The high mortality rate associated with cardiovascular disease is partially due to the lack of proliferative cells in the heart. Without adequate repair following myocardial infarction, progressive dilation can lead to heart failure. Stem cell therapies present one promising option for treating cardiovascular disease, though the specific mechanisms by which they benefit the heart remain unclear. Before stem cell therapies can be used safely in human populations, their biology must be investigated using innovative technologies such as multi-modality molecular imaging. The present review will discuss the basic principles, labelling techniques, clinical applications, and drawbacks associated with four major modalities: radionuclide imaging, magnetic resonance imaging, bioluminescence imaging, and fluorescence imaging.
Magnetic Resonance, stem cells, imaging, fluorescence, cell transplantation, radionuclide, bioluminescence
F. Bermpohl (1), A. Heinz (1), H. Walter (1)
Nervenheilkunde 2011 30 5: 313-319
A. I. C. Renwick (1), R. Dennis (2), T. J. Gemmill (1)
Vet Comp Orthop Traumatol 2010 23 4: 266-272
Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion
NOGA-guided subanalysis of the MYSTAR prospective randomised study
S. Charwat (1), I. Lang (1), M. Dettke (2), S. Graf (1), N. Nyolczas (1), R. Hemetsberger (1), S. Zamini (1), A. Khorsand (1), H. Sochor (1), G. Maurer (1), D. Glogar (1), M. Gyöngyösi (1)
Thromb Haemost 2010 103 3: 564-571
Women with atrial fibrillation have a much higher risk for thromboembolic stroke than men suffering...
Atrial fibrillation is the commonest heart rhythm condition. Women with atrial fibrillation...
Prothrombin complex concentrates (PCC) can rapidly normalise prolonged prothrombin time, induced...